- Home
- NERV vs RILY Comparison
NERV vs RILY Comparison
Compare NERV & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NERV | RILY |
|---|---|---|
| Founded | 2007 | 1973 |
| Country | United States | United States |
| Employees | N/A | 2056 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.6M | 232.6M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | NERV | RILY |
|---|---|---|
| Price | $7.85 | $6.84 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 160.1K | ★ 609.4K |
| Earning Date | 07-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,175,600.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $2.67 |
| 52 Week High | $12.46 | $10.97 |
Technical Indicators
Market Signals| Indicator | NERV | RILY |
|---|---|---|
| Relative Strength Index (RSI) | 67.71 | 44.77 |
| Support Level | $5.34 | $6.00 |
| Resistance Level | $12.46 | $7.15 |
| Average True Range (ATR) | 0.65 | 0.59 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 79.94 | 41.88 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About RILY B. Riley Financial Inc.
BRC Group Holdings Inc is a diversified holding company, including financial services, telecom, and retail, and investments in equity, debt and venture capital.